A survey on terminology and diagnostic features of a subgroup of non-cirrhotic portal hypertension patients: A report from asia-pacific experts

dc.authorid0000-0002-3559-5855
dc.authorid0000-0002-8909-2102
dc.authorid0000-0003-3590-2664
dc.authorid0000-0002-0544-5610
dc.contributor.authorShukla, Akash
dc.contributor.authorQi, Xiaolong
dc.contributor.authorÖrmeci, Necati
dc.contributor.authorDuseja, Ajay
dc.contributor.authorSarin, Shiv
dc.date.accessioned2026-11-05T10:42:02Z
dc.date.available2026-11-05T10:42:02Z
dc.date.issued2026
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractBackground: There have been recent proposals to replace non-cirrhotic portal fibrosis (NCPF), idiopathic portal hypertension (IPH), idiopathic non-cirrhotic portal hypertension, nodular regenerative hyperplasia, etc. with an all-encompassing term “porto-sinusoidal vascular disorder.” However, the Asia-Pacific Association for Study of the Liver recommended continued use of the term NCPF/IPH. Methods: We sent this questionnairebased online survey to capture the clinical perspectives of 300 specialized experts in the Asia-Pacific region with complete anonymisation. Results: The survey (n = 242 respondents) revealed overwhelming support for the continued use of the NCPF/IPH nomenclature, with 93.4% of experts favoring the term in daily practice. Furthermore, 80.1% endorsed liver histopathology as a fundamental diagnostic component, while 95.9% agreed that a lower-than-cirrhosis-range liver stiffness measurement obtained via transient elastography in the presence of portal hypertension is highly indicative of the condition.A total of 91% agreed with the APASL staging system. Conclusions: The results highlight a persistent regional consensus favoring a clinical, histological and portal hypertension–driven diagnostic and staging framework for NCPF. The survey reveals strong support for the continued use of the NCPF/IPH nomenclature. ( J CLIN EXP HEPATOL 2027;17:103671)
dc.identifier.citationShukla, A., Qi, X., Örmeci, N., Duseja, A., & Sarin, S. (2026). A survey on terminology and diagnostic features of a subgroup of non-cirrhotic portal hypertension patients: A report from asia-pacific experts. Journal of Clinical and Experimental Hepatology, 17(1), pp. 1-6. https://doi.org/10.1016/j.jceh.2026.103671
dc.identifier.doi10.1016/j.jceh.2026.103671
dc.identifier.endpage6
dc.identifier.issn2213-3453
dc.identifier.issn0973-6883
dc.identifier.issue1
dc.identifier.pmidPMID: 42893017
dc.identifier.scopus2-s2.0-105052582096
dc.identifier.scopusqualityQ2
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.1016/j.jceh.2026.103671
dc.identifier.urihttps://hdl.handle.net/20.500.13055/1692
dc.identifier.volume17
dc.identifier.wosWOS:001901769500001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.otherESCI - Emerging Sources Citation Index
dc.institutionauthorÖrmeci, Necati
dc.institutionauthorid0000-0002-8909-2102
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Clinical and Experimental Hepatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPortal Hypertension
dc.subjectPortal Sinusoidal Vascular Disorder
dc.subjectVascular Liver Disorders
dc.subjectNon-Cirrhotic Portal Hypertension
dc.subjectNodular Regenerative Hyperplasia
dc.subjectObliterative Portal Venopathy
dc.titleA survey on terminology and diagnostic features of a subgroup of non-cirrhotic portal hypertension patients: A report from asia-pacific experts
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
Tam Metin / Full Text.pdf
Boyut:
413.98 KB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: